NCT05982886View on ClinicalTrials.gov

Biomarker Testing and Treatment Patterns Among Patients With PIK3CA Mutation in Advanced Breast Cancer

CompletedOBSERVATIONAL
Enrollment

1,093

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
Breast Cancer
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY